Where this Hodgkin lymphoma information comes from | Cancer Research UK
Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Where this Hodgkin lymphoma information comes from

Men and women discussing Hodgkin's lymphoma

On this page are the major sources of information that we use to put together this section on Hodgkin lymphoma.


About this page

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had Hodgkin lymphoma (Hodgkin's disease), live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.



Cancer Research UK
CancerStats Series

US National Cancer Institute
Information on the treatment of Hodgkin lymphoma



Principles and practice of oncology (9th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Wiliams and Wilkins, 2011

Cancer and its management (6th edition)
Tobias J and Hochhauser D
Blackwell Publishing Ltd, 2010

Essential Haematology (6th Edition)
Hoffbrand V and Moss P
Wiley-Blackwell, 2011


UK Guidelines

Improving outcomes in haematological cancer.
The national Institute for Health and Care Excellence (NICE), 2003
Link to the NICE haematological cancer guidance

Referral for suspected cancer. A clinical practice guideline.
The National Institute for Health and Care Excellence (NICE), June 2015
Link to the referral guidelines on the NICE website

NHS Evidence
Hodgkin's lymphoma map of medicine
Link to the Hodgkin's lymphoma map of medicine

Guidelines for the first line management of classical Hodgkin lymphoma.
British Committee for Standards in Haematology (BCSH), Feb 2014
Link to the BCSH guidelines


Articles and reviews

Hodgkin's lymphoma in adults. Townsend W, Linch D, The Lancet, 1 September 2012; 380: 836-47.

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Eichenauer D, Engert A et al: Annals of Oncology (2014).

Novel therapy for Hodgkin lymphoma: Batlevi CL, Younes A: American Society of Hameatology (2013).

Developments in the management of Hodgkin’s lymphoma. Lowry L,  Hoskin P,  Linch D. Comment in The Lancet. 19 February, 2010.

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Schulz H, Rehwald U, Morschhauser F, Elter T, Driessen C, Ru T, Borchmann P, Schnell R, Diehl V, Engert A, Reiser M. Blood: 1 January 2008; Vol 111, No 1. 

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Koh E, Huan Tran T, Heydarian M, Rainer K, Tsang R, Brenner D, Pintilie M, Xu T, Chung J, Paul N, Hodgson D. Radiation Oncology 2007, 2:13.

Management of Hodgkin Lymphoma. Ansell, S.M, and Armitage, J. O. Mayo Clinic Proceedings (2006) 81; (3); 419-26.

Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk. Franklin J. G, Paus M. D, Pluetschow A, Specht L. Cochrane Database of Systematic Reviews 2005, Issue 4.

Hodgkin's Lymphoma. Yung, L and Linch, D.  The Lancet, March 2003; 361; (9361); 943-951


Specialist reviewers

Dr P Mahendra MD FRCP FRCPath



Dee McLean - McDee Art, Medical Illustration

Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 6 January 2015